Articles tagged with Hiv Infections
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A team of scientists has identified the 'key' that HIV uses to enter cells' nuclei, allowing it to disable the immune system and cause AIDS. By targeting proteins in the host rather than the virus itself, researchers hope to develop more effective anti-AIDS drugs against drug-resistant strains.
A recent study from UNC at Chapel Hill may help explain the failure of some HIV prevention clinical trials and suggests ways to improve their success. The study found that drug concentrations in tissue can make a difference in effectiveness, and adherence to taking the drug as prescribed is crucial.
UCLA researchers propose an unconventional approach to controlling HIV epidemics by implementing PrEP programs in areas with low treatment success and high drug resistance rates. This strategy aims to decrease the number of infections, resulting in a greater decrease in drug resistance.
In Malawi, people with uncertain HIV status are more eager to start families than those who know their status. Researchers found that uncertainty about HIV accelerates childbearing in the country due to cultural factors and the desire for a longer life. The study used an innovative method to measure personal uncertainty, where particip...
A study published in PLOS ONE found that Danish HIV patients with optimal treatment can live as long as the general population. The study, which has been tracking HIV patients for over 15 years, shows that patients are not as ill on diagnosis and have higher CD4 cell counts. This suggests that early treatment and better care may be con...
A Scripps Florida scientist has received a $3.4 million grant to study a new compound that blocks HIV replication by targeting the viral protein Tat. The goal is to evaluate its therapeutic potential in animal models and optimize it for human clinical trials, potentially leading to a novel class of anti-viral drugs.
Researchers at Caltech have successfully delivered neutralizing antibodies to mice using Vectored ImmunoProphylaxis (VIP), a novel approach to HIV prevention. The treatment effectively protected the mice from HIV infection and produced high concentrations of broadly neutralizing antibodies that may translate to human protection.
A rare type of HIV-infection, group N, has been diagnosed in a man in France who recently travelled to Togo, marking the first detection outside Cameroon. The patient exhibited severe clinical manifestations and early decline in CD4 cell count, but responded well to antiretroviral treatment.
Researchers found that providing prophylaxis to the uninfected partner could be cost-effective, at least as effective as initiating antiretroviral therapy earlier. This strategy may become a valuable addition to existing HIV prevention approaches.
Dr. Andrés Finzi's 'Reverse Fusion' project aims to deliver toxic genes to HIV-infected cells to eliminate them. The approach targets the virus's unique key and lock, using modified envelope glycoproteins and receptors to deliver a Trojan horse that eradicates infected cells.
A topical gel containing an anti-HIV drug was found to be safe and effective in reducing HIV infection when applied to rectal tissue exposed to HIV. The study suggests a significant reduction in HIV transmission, particularly for receptive anal intercourse, which accounts for a major route of new infections.
St. Michael's Hospital has received funding to develop a human endogenous retrovirus (HERV) vaccine that could eliminate latent HIV reservoirs. The project aims to target persistent viruses hiding in the body, with the goal of eliminating HIV from infected individuals.
A recent HIV study has identified SAMHD1, a protein that prevents the virus from replicating in certain cells. The research provides a blueprint for designing new drugs to treat HIV infection.
A potential EBV vaccine could prevent infectious mononucleosis and cancers linked to the virus. Researchers prioritize studying immune responses to vaccination and identifying biological markers for cancer prediction.
A new report questions adequacy of disinfection regulations in nail salons and barbershops, suggesting potential transmission of bloodborne pathogens. The study emphasizes the need for further research to define the true magnitude of this risk.
Researchers aim to evaluate the efficacy and cost-effectiveness of a peer-driven intervention to reach, test, and retain heterosexuals at high risk for HIV in their communities. The study will enroll 3400 participants over five years.
Researchers have discovered a compound that shuts off the DNA valve allowing bacterial invasion and infection, effective against two virulent bacteria affecting plants and humans. The work has attracted interest from private companies testing its commercialization for treatments in plants, animals, and people.
The UCSF Center for AIDS Prevention Studies will receive funding to tackle two primary goals of the National AIDS Strategy: increasing access to care and optimizing health outcomes. The program aims to close gaps in HIV testing, linkage to care, and treatment success among high-risk populations.
A French study found that non-targeted HIV rapid test screening in emergency departments identified only a few new cases, often at late stages and among patients in high-risk groups who had been tested previously. The study suggests that targeted HIV screening strategies may be more effective in controlling the epidemic.
Natural Killer cells play a critical role in early immune responses to tumours and viruses, exploiting HLA molecules on healthy cells to launch attacks. The research may help develop approaches to better utilize Natural Killer cells to combat viral infection.
A new study found that a topical gel formulation of tenofovir significantly reduces HIV-1 transmission while also protecting against herpes simplex virus (HSV) infection. The researchers discovered that the drug's effectiveness against HSV was due to its ability to inhibit an enzyme needed for viral replication.
A mathematical model predicts that expanding HIV treatment to discordant couples in Ghana, Lesotho, Malawi, and Rwanda can prevent 96% of transmission. The intervention's effectiveness varies by country, with potential for significant impact in certain nations.
Researchers at Miriam Hospital demonstrated a practical strategy for regularly screening HIV-infected patients for acute hepatitis C virus infection, which can lead to serious health complications. The study found that even in a busy clinic setting, it is possible to screen for and diagnose HCV in its earliest stages.
CONRAD will develop and test the safety and effectiveness of a combined contraceptive barrier and HIV-prevention product, supported by a $2 million USAID award. The study aims to provide women with non-hormonal, easy-to-use methods for preventing unintended pregnancy and sexually transmitted infections.
Scientists have developed new substances that first block the biological vacuum cleaner preventing anti-HIV drugs from reaching the brain and then revert to an active drug to treat HIV. This breakthrough allows medications to cross the blood-brain barrier, targeting brain diseases and potentially offering a cure for HIV.
A five-year HIV prevention initiative in India, Avahan, has successfully averted an estimated 100,000 infections. The program's effectiveness varied across states, with southern regions showing more significant reductions in HIV prevalence.
Healthcare access in Greece declined during the financial crisis, with long waiting times and supply-side problems contributing to reduced doctor consultations. This led to increased hospital admissions, suicides, and other alarming indicators such as rising HIV infections and heroin use.
Researchers aim to develop a safe and effective vaccine against Pneumocystis, a deadly fungus causing HIV-related pneumonia. The project has the potential to lower treatment costs and improve quality of life for individuals living with HIV.
Researchers have discovered a crucial gene that boosts antibody responses against retroviruses, including HIV. The discovery highlights the potential for targeted therapies to enhance antibody production and combat viral infections.
Measurable changes in brain function and communication between regions may indicate disease progression in early HIV infection. Cognitive decline is associated with reduced survival time and increased risk of death.
Researchers have discovered two genetically distinct HIV types in the cerebrospinal fluid of patients with HIV-associated dementia, which may predict disease progression and cognitive damage. The study found that one variant infects macrophages, a type of white blood cell, while the other reproduces in T cells.
A University of Washington-led study found that using hormonal contraception increases an HIV-uninfected woman's chances of becoming infected by double. Women with HIV who use hormonal contraception are also twice as likely to transmit the virus to their male partners.
A study of nearly 3800 couples found that hormonal contraception increases a woman's chances of becoming infected with HIV-1. Women using injectable methods were twice as likely to transmit the virus to their male partner, emphasizing the need for alternative methods.
The VOICE study will discontinue evaluating oral tenofovir due to lack of effectiveness, while continuing to investigate tenofovir gel and PrEP. This decision was made after an interim review found no safety concerns with oral tenofovir.
The MVA-B vaccine has been shown to induce an 90% immune response in humans against Human's immunodeficiency virus (HIV), with 85% of volunteers maintaining this response for at least one year. The vaccine works by training the immune system to recognize and respond to HIV particles and infected cells.
Researchers at Johns Hopkins have modified HIV to trigger an immune response, a major hurdle in vaccine development. The altered virus activates the adaptive immune system's response against HIV, negating its immunosuppressive properties.
Scientists have discovered a key to predicting emerging diseases like HIV, SARS, and flu by studying how viruses infect different species. By analyzing the relationships between species and viruses, researchers found that closely related flies are more susceptible to certain viruses.
Researchers have discovered a new class of compounds that stick to the sugary coating of the AIDS virus and inhibit its entry into cells. The synthetic lectins, developed from a compound called benzoboroxole, show promise as a potential microbicide to prevent HIV infection.
Researchers will evaluate the impact and cost-effectiveness of a unique combination of HIV prevention strategies in Botswana, aiming to reduce infections by at least 50%. The study will analyze viral gene signatures and examine the effectiveness of targeting individuals with high viral loads.
Researchers at Children's Hospital Boston developed liposomes that can prevent HIV infection, providing a potential solution for women in resource-poor settings. The innovative technology shows great promise as a safe and effective form of prevention.
A $37 million grant has been awarded to test a combination prevention strategy to prevent HIV in African countries. The PopART project aims to reduce new HIV infections through community-wide testing, medical circumcision, and immediate ART for those testing positive.
The SILCS Diaphragm, a single-size contoured diaphragm, has shown effectiveness rates similar to traditional diaphragms, and is easy to use and comfortable to wear. This new contraceptive method offers women more control over their reproductive health, particularly in low-resource settings.
Researchers have identified two weak points in the hepatitis C virus that could be targeted by a new vaccine. The discovery uses next-generation deep sequencing and computer analytics to track changes in the virus after infection, revealing opportunities for effective vaccine development.
Dr. John G. Bartlett has been recognized for his outstanding contributions to antimicrobial chemotherapy and infectious diseases research. He is a pioneer in understanding emerging problems and innovations in the field.
Scientists are working on structure-based HIV vaccines and understanding the evolutionary processes of human B cells producing broadly neutralizing antibodies. New research tools and a better understanding of the human immune response offer optimism for developing an effective HIV vaccine.
Researchers created a Facebook application called PiggyDemic to simulate viral interactions and gather data on how viruses spread among populations. The app can predict patterns of infection, seasonal outbreaks, and the impact of human interaction on viral dynamics.
New HIV cases linked to infected, medicated partners in gay community, suggesting a need for revised public health approach towards HIV counselling and education. The study reveals that existing HIV drug therapies can't prevent transmission from aware, medicated individuals.
Researchers at Brigham and Women's Hospital identified a novel small molecule that inhibits Ebola virus entry into cells by more than 99 percent. The target of the inhibitor is the cell protein Niemann-Pick C1, which is critical for EboV infection.
A George Mason University research team has uncovered a new factor, LIMK, that triggers cell movement essential for HIV infection. The discovery builds upon previous findings and provides a potential therapeutic target to limit or halt HIV infection.
Memory T cells that initially developed against a virus upon first encounter can be lost during chronic infections, making it challenging for vaccine development. Researchers at the Emory Vaccine Center have identified a molecule called 2B4 on memory cells that slows them down during chronic infections.
Researchers at Caltech propose that cell-to-cell transmission of HIV is responsible for the formation of viral reservoirs. This mechanism allows HIV to persist in infected cells despite antiretroviral therapy.
A USC scientist has created a lentiviral vector that targets and destroys HIV-infected cells using 'suicide gene therapy', depleting about 35% of existing HIV cells in culture dishes. The treatment approach is an important step towards curing HIV and will be tested in mice next.
Researchers at Montana State University found a surprising condition where common lung mold causes a shortage of oxygen in the lungs. The study reveals that the mold's fermentation can influence the host immune response and adapt to low oxygen levels.
A new study shows natural killer cells can contribute to HIV immune response, suggesting an additional cell type with anti-HIV activity. Researchers found that HIV strains infecting individuals with specific NK cell receptors had variant forms of viral proteins, implying the virus mutates to avoid NK cell activity.
Researchers at Caltech have developed a new, more potent form of the HIV-fighting protein cyanovirin-N by linking two proteins together. The engineered protein, called CVN2L0, is 18 times more effective at preventing infection than the naturally occurring single protein and neutralizes all 33 subtypes of HIV tested against it.
The study estimates that around 10 million injecting drug users globally are infected with HCV, while 1.3 million have HBV infection. The authors emphasize the need for increased attention to viral hepatitis in IDUs and enhanced access to treatments.
The article highlights the connection between neglected tropical diseases (NTDs) and HIV/AIDS, proposing ways to integrate NTD treatment programs with HIV/AIDS initiatives. Studies show that areas with high NTD infection rates also have high HIV/AIDS prevalence, and co-infections can exacerbate HIV/AIDS.
A new study suggests that adopting the World Health Organization's treatment initiation criteria for HIV-infected individuals would significantly reduce the country's HIV incidence, extend life-years, and ultimately save money. By starting ART earlier, South Africa could prevent more than 120,000 additional life-years by 2040.
Cell biologists from the University of Zurich have identified the infection mechanism for type-5 adenoviruses, revealing that viruses use scavenger cells to trigger an immune response and expose shielded receptors on lung epithelial cells. This discovery has implications for both gene therapy and cancer treatment.
Researchers from BUSM and BMC will implement a clinical model to coordinate narcology and HIV systems of care in Russia, aiming to increase engagement in medical care among HIV-infected IDUs. The LINC project aims to address the missed opportunity of delayed or non-receipt of HIV medical care in Russia.